Signaling inputs converge on nuclear effectors in TGF-β signaling

Trends in Biochemical Sciences

Volumn 25, Issue 2, 2000, Pages 64-70

  Ten Dijke, Peter ^a   Miyazono, Kohei ^b   Heldin, Carl Henrik ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Sweden)

^b CANCER INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; ISOPROTEIN; PROTEIN SERINE THREONINE KINASE; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

CELL SPECIFICITY; GENE EXPRESSION REGULATION; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; REACTION ANALYSIS; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; DNA; DNA-BINDING PROTEINS; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD6 PROTEIN; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0033956131     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0004(99)01519-4     Document Type: Review

References (40)

1. Massagué J. TGF-β signal transduction. Annu. Rev. Biochem. 67:1998;753-791.
2. Masuyama N.et al. Identification of two Smad4 proteins in Xenopus. Their common and distinct properties. J. Biol. Chem. 274:1999;12163-12170.
3. Howell M.et al. Xenopus Smad4β is the Co-smad component of developmentally regulated transcription factor complexes responsible for induction of early mesodermal genes. Dev. Biol. 214:1999;354-369.
4. Lo R.S.et al. The L3 loop: a structural motif determining specific interactions between SMAD proteins and TGF-β receptors. EMBO J. 17:1998;996-1005.
5. Chen Y.G., Massagué J. Smad1 recognition and activation by the ALK1 group of transforming growth factor-β family receptors. J. Biol. Chem. 274:1999;3672-3677.
6. Tsukazaki T.et al. SARA, a FYVE domain protein that recruits Smad2 to the TGFβ receptor. Cell. 95:1998;779-791.
7. Chen Y.G.et al. Determinants of specificity in TGF-β signal transduction. Genes Dev. 12:1999;2144-2152.
8. Kawabata M.et al. Smad proteins exist as monomers in vivo and undergo homo- and hetero-oligomerization upon activation by serine/threonine kinase receptors. EMBO J. 17:1998;4056-4065.
9. Shi X.et al. A structural basis for mutational inactivation of the tumour suppressor Smad4. Nature. 388:1999;87-93.
10. Yingling J.M.et al. Tumor suppressor Smad4 is a transforming growth factor β-inducible DNA binding protein. Mol. Cell. Biol. 17:1997;7019-7028.
11. Zawel L.et al. Human Smad3 and Smad4 are sequence-specific transcription activators. Mol. Cell. 1:1998;611-617.
12. Dennler S.et al. Direct binding of Smad3 and Smad4 to critical TGFβ-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17:1998;3091-3100.
13. Shi Y.et al. Crystal structure of a Smad MH1 domain bound to DNA: insights on DNA binding in TGF-β signaling. Cell. 94:1999;585-594.
14. Zhang Y.et al. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription. Nature. 394:1998;909-913.
15. Labbé E.et al. Smad2 and Smad3 positively and negatively regulate TGFβ-dependent transcription through the forkhead DNA-binding protein FAST2. Mol. Cell. 2:1998;109-120.
16. Chen X.et al. Smad4 and FAST-1 in the assembly of activin-responsive factor. Nature. 389:1997;85-89.
17. Hua X.X.et al. Synergistic cooperation of TFE3 and Smad proteins in TGF-β-induced transcription of the plasminogen activator inhibitor-1 gene. Genes Dev. 12:1998;3084-3095.
18. Sano Y.et al. ATF-2 is a common nuclear target of Smad and TAK1 pathways in transforming growth factor-β signaling. J. Biol. Chem. 274:1999;8949-8957.
19. Xie X.Q.et al. AML and Ets proteins regulate the Iα1 germ-line promoter. Eur. J. Immunol. 29:1999;488-498.
20. Nakashima K.et al. Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300. Science. 284:1999;479-482.
21. Moustakas A., Kardassis D. Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. Proc. Natl. Acad. Sci. U. S. A. 95:1998;6733-6738.
22. Shi X.et al. Smad1 interacts with homeobox DNA-binding proteins in bone morphogenetic protein signaling. J. Biol. Chem. 274:1999;13711-13717.
23. Kurokawa M.et al. The t(3;21) fusion product, AML1/Evi-1, interacts with Smad3 and blocks transforming growth factor-β-mediated growth inhibition of myeloid cells. Blood. 92:1999;4003-4012.
24. Zhang Y., Derynck R. Regulation of Smad signalling by protein associations and signalling crosstalk. Trends Cell Biol. 9:1999;274-279.
25. Feng X.H.et al. The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for Smad3 in TGF-β-induced transcriptional activation. Genes Dev. 12:1998;2153-2163.
26. Janknecht R.et al. TGF-β-stimulated cooperation of Smad proteins with the coactivators CBP/p300. Genes Dev. 12:1998;2114-2119.
27. Wotton D.et al. A Smad transcriptional corepressor. Cell. 97:1999;29-39.
28. Luo K.et al. The Ski oncoprotein interacts with the Smad proteins to repress TGFβ signaling. Genes Dev. 13:1999;2196-2206.
29. Sun Y.et al. Interaction of the Ski oncoprotein with Smad3 regulates TGF-β signaling. Mol. Cell. 4:1999;499-509.
30. Akiyoshi S.et al. c-Ski acts as a transcriptional co-repressor in transforming growth factor-β signaling through interaction with Smads. J. Biol. Chem. 274:1999;35269-35277.
31. Sun Y.et al. SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor β signaling. Proc. Natl. Acad. Sci. U. S. A. 96:1999;12442-12447.
32. Stroschein S.L.et al. Negative feedback regulation of TGF-β signaling by the SnoN oncoprotein. Science. 286:1999;771-774.
33. Ulloa L.et al. Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway. Nature. 397:1999;710-713.
34. Kretzschmar M.et al. A mechanism of repression of TGFβ/Smad signaling by oncogenic Ras. Genes Dev. 13:1999;804-816.
35. Zhu H.et al. A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature. 400:1999;687-693.
36. Lo R.S., Massagué J. Ubiquitin-dependent degradation of TGF-β -activated Smad2. Nat. Cell Biol. 1:1999;472-478.
37. Hocevar B.A.et al. TGF-β induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J. 18:1999;1345-1356.
38. Yang X.et al. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T-cell responsiveness to TGF-β EMBO J. 18:1999;1280-1291.
39. Datto M.B.et al. Targeted disruption of Smad3 reveals an essential role in transforming growth factor β-mediated signal transduction. Mol. Cell. Biol. 19:1999;2495-2504.
40. Zhu Y.et al. Smad3 mutant mice develop metastatic colorectal cancer. Cell. 94:1998;703-714.